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S U M M A R Y
Objective: The objective of this study was to predict the diagnosis of bacteraemia as a function of the time
at which the automated BacT/Alert system continuously detects microorganism growth.
Methods: A retrospective study of a database of 1334 patients with a positive blood culture between
January 2011 and June 2013 was conducted. Together with the ﬁnal blood culture results and the
patient’s history, growth was then analysed to assess whether it represented true bacteraemia or
bacterial contamination. The earliest detection times of bacterial growth in each batch of blood cultures
were analysed in a blinded fashion after classiﬁcation.
Results: In total, 590 batches of blood cultures corresponded to true bacteraemia and 744 to bacterial
contamination. In the bacteraemia group, the median growth time was 12.72 h (interquartile range (IQR)
10.08–17.58 h). In the contaminated blood culture group, the median growth time was 20.6 h (IQR
17.04–32.16 h) (p < 0.001). Analysis of the receiver operating characteristics (ROC) curve (area under the
curve 0.80, 95% conﬁdence interval 0.771–0.826) showed that 90% of the contaminants grew after 14.7 h
(sensitivity 90.5%, speciﬁcity 63.4%, positive predictive value (PPV) 65.9%, negative predictive value
(NPV) 90.7%). Forty-ﬁve percent of the bacteraemia organisms grew in under 12 h (sensitivity 45.3%,
speciﬁcity 95%, PPV 87.8%, NPV 68.7%). Microorganisms such as Candida sp and Bacteroides sp presented
median growth times signiﬁcantly longer than those of the other microorganisms. The administration of
antibiotics in the week prior to bacteraemia was found to delay the growth time of microorganisms
(p < 0.001).
Conclusions: Knowing the time to detection of microorganism growth can help to distinguish between
true bacteraemia and bacterial contamination, thus allowing more timely clinical decisions to be made,
before deﬁnitive microorganism identiﬁcation.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The diagnosis of bacteraemia is one of the most critical
functions of clinical microbiology laboratories. In general, conven-
tional blood culture methods (manual systems such as biphasic
blood culture, lysis ﬁltration–centrifugation, manometer methods,
and automatic systems, both radiometric and non-radiometric)
provide results within 2 to 5 days, and incubation periods of over
5 days are not usually required with modern continuous
automated monitoring methods.1,2 The volume of blood extracted* Corresponding author. Tel.: +34 16006179.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).for each blood culture is the most important variable when
harvesting bacteria and fungi from patients with bacteraemia.1–3
Contamination of blood culture is common, is very costly for the
health system, and often confuses clinicians. To minimize the risk
of blood culture contamination with the normal skin ﬂora,
meticulous attention should be paid when preparing the skin
for venipuncture. In general, it is desirable to maintain the rate of
contaminated blood culture at less than 3%. Rates of contamination
any higher than this should be investigated and corrected with
educational efforts.4
Clinicians should be notiﬁed every time there is a positive blood
culture because the microorganism can often represent an
infection that may lead to death. Furthermore, knowledge of the
start times for adequate antibiotic therapy is critical for theciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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between mortality and the origin of bacteraemia appears to
depend on the use and timing of treatment with adequate
empirical antibiotics.5–7
The objective of this study was to predict the diagnosis of
bacteraemia in the face of contaminants as a function of the time at
which the automated BacT/Alert system continuously detects
microorganism growth, and to identify whether this time to
detection can help the clinician to distinguish true-positive growth
from contaminated growth. This study also analysed whether
taking antibiotics during the 7 days before bacteraemia inﬂuences
culture growth times.
2. Methods
The study was conducted in a referral hospital serving the
population of the southern part of the Community of Madrid.
According to data from the National Institute of Statistics dating
from January 1, 2012, this facility covers a health area of 224 549
inhabitants, of whom 171 164 are aged >14 years. The hospital is a
350-bed secondary hospital with general surgery, orthopaedics,
urology, gynaecology and obstetrics, internal medicine, intensive
care, cardiology, digestive system, pneumology, nephrology,
oncology, haematology, and paediatric units.
The growth time in hours from the ﬁrst vial of each blood
culture batch in which microorganism growth was produced in a
suspected case of bacteraemia was recorded retrospectively for
cultures performed during the period January 2011 to June
2013. All subjects were non-paediatric patients aged >14 years.
A retrospective study of this database was then performed.
Together with the ﬁnal blood culture results and the patient’s
history (146 different clinical, analytical, and epidemiological
variables were recovered), the growth and treatment received
were analysed in a blinded fashion by four different clinicians to
assess whether the growth represented true bacteraemia or
bacterial contamination. The data were analysed using SPSS
statistical software (version 15.0). The distribution of these times
was studied to decide whether to work with the mean and
standard deviation or with the median and interquartile range.
Non-parametric tests of the median were conducted to calculate
any signiﬁcant differences between medians. A receiver operating
characteristics (ROC) curve was also produced to determine the
sensitivity, speciﬁcity, positive predictive value (PPV), and nega-
tive predictive value (NPV) for the different growth times. The
unpaired Student’s t-test or Mann–Whitney U-test was used for
the analysis of quantitative data.
During the study period, the BacT/Alert blood culture system
was employed. Two pairs of blood culture vials were used for each
patient, with a total recommended extracted volume of blood of
20–40 ml. These four vials, two for aerobic and two for anaerobic
culture, were termed a ‘blood culture batch’. Blood cultures were
performed depending on medical criteria in patients with
suspected sepsis; there is no predictive model able to identify
which patients should have blood cultures done.
A blood culture was considered to be a true positive
(bacteraemia) when at least one of the following microorganisms
was isolated in at least one blood culture vial: Gram-negative
bacilli, fungi, and Gram-positive cocci different from coagulase-
negative Staphylococcus. A blood culture was also considered to be
a true positive when coagulase-negative Staphylococcus was
isolated in at least one vial of each pair and the patient presented a
compatible clinical workup of bacteraemia. The blood culture was
considered contaminated when coagulase-negative Staphylococ-
cus, Bacillus sp, Propionibacterium acnes, or Corynebacterium sp was
isolated in a single vial without any clinical indication. When
coagulase-negative Staphylococcus isolated from a single vial wasassociated with intravascular catheter colonization (over 15 colo-
ny-forming units) caused by the same microorganism, the blood
culture was considered positive if the patient’s doctor initiated
treatment based on this result. The growth time in hours was
deﬁned as the time elapsed between incubation and the detection
of growth utilizing the automated blood culture system.
The same episode was considered bacteraemia if a new
extraction with growth of the same microorganism was produced
in the 5 days following the ﬁrst extraction.
Patients were considered to have received prior antibiotic
therapy if they received at least one dose of antibiotics in the 7 days
prior to the blood culture. This information was analysed only in
bacteraemic patients.
3. Results
During the study period from January 2011 to June 2013,
6816 blood culture batches were collected from patients older than
14 years of age. From this total, 1350 positive blood culture batches
were associated with 1334 episodes of suspected bacteraemia;
590 of these corresponded to true bacteraemia and 744 were
classiﬁed as contaminated blood culture batches.
3.1. Microorganisms
Of the 1334 blood culture batches with growth in the blood
culture vials, true-positive bacteraemia (n = 590) was produced by
enterobacteria (46.8%), coagulase-negative Staphylococcus (15.2%),
Staphylococcus aureus (8.3%), polymicrobial infections (5.4%),
Enterococcus sp (5.3%), non-fermenting Gram-negative bacilli
(4.2%), Streptococcus pneumoniae (2.5%), Candida sp (2%), and
Streptococcus agalactiae (1%).
Of the contaminated blood cultures (n = 744), coagulase-nega-
tive Staphylococcus made up 70.2%, Propionibacterium sp 9.5%,
polymicrobial microorganisms 8.2%, and Corynebacterium sp 4.6%.
3.2. Growth times of contaminated and true-positive blood cultures
The growth time of the contaminated blood cultures (n = 744)
was a median 20.6 h (IQR 17.04–32.16 h). Regarding the true-
positive blood culture bacteraemia (n = 590), the growth time was
a median 12.72 h (IQR 10.08–17.58 h). The difference between the
two growth times was statistically signiﬁcant (p < 0.001).
A ROC curve (Figure 1) was produced to determine the
sensitivity, speciﬁcity, PPV, and NPV of the growth time as a
determinant of contaminated growth. The area under the curve
was 0.80, with a 95% conﬁdence interval of 0.771–0.826.
In true bacteraemia, if the ﬁrst vial detecting microorganism
growth did so in less than 12 h, a speciﬁcity of over 95% and
sensitivity of 45.3 % was found (PPV 87.8%, NPV 68.7%). In total, 90%
of the contaminants grew beyond 14.7 h (sensitivity 90.5%,
speciﬁcity 63.4%, PPV 65.9%, NPV 90.7%) and 95% of the con-
taminants grew beyond 12 h (sensitivity 95%, speciﬁcity 43.6%, PPV
57.8%, NPV 92.1%).
Comparing the growth times between distinct microorganisms
producing true bacteraemia, there were microorganisms with
signiﬁcantly slower growth than others, as was the case with
Bacteroides sp and Candida sp (Table 1) (Figures 2 and 3).
Comparing the growth times of coagulase-negative staphylo-
cocci in bacteraemia cases (90 cases; median 16.32 h, IQR 12.84–
19.92 h) to the growth times of coagulase-negative staphylococci
considered to be a contaminant (538 cases; median 19.20 h, IQR
16.80–24.72 h), the difference in growth times was found to be
statistically signiﬁcant with p < 0.001 (Figures 2 and 3).
Analyses of the growth times of true bacteraemia according to
whether the patient received antibiotic therapy in the week prior















Figure 2. Growth times in hours of tr
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which this information was collected.
3.3. Bacteraemia without antibiotic therapy in the week prior to the
event
In total, 419 patients with bacteraemia had not received
antibiotic therapy in the week prior to blood culture collection. In
233 patients (55.6%), the microorganism responsible for the
bacteraemia grew in less time than the median time for all
bacteraemia (12.72 h of 590 bacteraemia). The median time to
growth in the group of true bacteraemia from patients who had not
received antibiotic therapy in the week prior to diagnosis was 12 h
(IQR 9.84–15.96 h).
3.4. Bacteraemia with antibiotic therapy in the week prior to the event
In total, 128 patients with bacteraemia had received prior
antibiotic therapy, and of these patients, 45 (35.2%) had cultures
that grew in less time than the median time for all bacteraemia
(12.72 h of 590 bacteraemia). The median in the group of true
bacteraemia involving patients who had received antibiotic
therapy was 14.16 h (IQR 11.28–20.40 h).
The administration of antibiotics in the week prior to acquiring
bacteraemia was found to signiﬁcantly slow and delay the growth
time of microorganisms in blood culture vials (p < 0.001).
4. Discussion
Based on the results presented, the time at which microorgan-





Growth times in hours by quartiles of the principle microorganisms responsible for bacteraemia: 507 cases
Microorganism (cases: 507/590) 25% Median 75% p-Value (difference in growth times)
Enterobacteria (n = 276) 9.6 11.28 13.68 <0.001
Enterobacteria/non-fermented Gram-negative bacilliNon-fermenting Gram-negative bacilli (n = 25) 12.84 16.92 19.32
Coagulase-negative Staphylococcus (n = 90) 13.2 16.32 19.92 <0.001
Coagulase-negative Staphylococcus/all other Gram-positive cocciEnterococcus sp (n = 31) 12.72 13.92 15.84
Streptococcus pneumoniae (n = 15) 8.64 10.56 12
Staphylococcus aureus (n = 49) 9.84 12.48 16.32
Clostridium sp (n = 4) 8.28 11.16 25.2
Bacteroides sp (n = 5) 24.48 28.8 39.6 <0.016
Bacteroides and Candida/all other microorganismsCandida sp (n = 12) 25.98 39.96 50.12
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bacteraemia, with a high speciﬁcity at 95% and an important
sensitivity of over 45.3 % if this growth is produced in the ﬁrst 12 h
after incubation.
With regard to this timescale, it must be considered that
distinct types of microorganism, such as Bacteroides sp and Candida
sp, have signiﬁcantly slower growth times than other microorgan-
isms.
Several investigations have described a correlation between
high bacterial load and faster growth times. Thus, it has been
suggested that growth time could be a marker of bacterial load.8,9
Some researchers have found that the time it takes for a blood
culture to provide a positive test result can help to indicate the
origin of bacteraemia produced by S. aureus. If the patient has not
received antibiotic treatment and the blood culture is obtained by
venipuncture, a growth time of less than 14 h suggests the





Figure 3. Growth times in hours ofrelated to the higher bacterial load in intravascular locations,
which would explain faster culture growth times.
This pattern could explain why contaminated blood cultures
have slower growth times than uncontaminated cultures – by the
mere fact that the bacterial load is lower in contaminated blood
cultures than in cultures from patients with an active infection. It is
important to highlight that bacteria often found as contaminants
are not necessarily non-pathogens. Currently all microorganisms
may be a pathogenic agent and therefore cannot be ignored.
The prior administration of antibiotic therapy will also delay
microorganism growth times in blood culture vials. The reason for
the delay in growth could be the fact that prior antibiotic therapy
reduces the bacterial load or even complicates the growth,
inhibiting it completely in blood culture vials. To date, we have
not been able to identify any reports in the literature conﬁrming
the data described or that quantify the delay in growth times if the
patient has received prior antibiotic therapy.Hours
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that was not analysed in this study, is the blood extraction volume
per vial. The routine use of blood volumes of at least 30 ml is based
on prior studies in which the authors have shown that the optimal
volume of blood extraction for the diagnosis of bacteraemia is 20–
30 ml.12,13 The presence of an inadequate volume of blood in a
culture vial could imply a lower bacterial load and longer growth
times.
Knowledge of these growth times could inform the clinician of
the existence of true bacteraemia several hours before the
deﬁnitive identiﬁcation of the microorganism responsible. At this
time it would be sufﬁcient to collect the times at which
microorganism growth is detected in blood culture vials using
the automated BacT/Alert system. In addition, this time to growth
could help clinicians to distinguish bacteraemia from contamina-
tion due to coagulase-negative Staphylococcus, depending on the
number of bottles in which the microorganism is detected.
The signiﬁcant delay observed in the growth times of Candida is
noteworthy. It is known that the yield of Candida in blood cultures
is approximately 50–70%.14 Mortality in the group of patients with
invasive candidiasis is between 40% and 60%.15,16 Various models
and predictive scales for candidaemia have been attempted, but
the fundamental utility of the majority of these models is the
exclusion of candidaemia and not its diagnosis.17–22 The delayed
growth times of Candida together with insufﬁcient harvesting of
this microorganism for its diagnosis could suggest the need to
conﬁrm whether prolonged incubation times of blood cultures
from patients suspected to have candidaemia could increase the
value of these blood cultures given the signiﬁcant delay that the
growth times present.
There are limitations to these results due to the study has been
performed at a single centre. It was not determined whether the
volume of blood extracted was correct, although recommendation
is at least 20 ml for each patient. Furthermore, the time between
blood extraction and the beginning of the incubation period was
not monitored, although this should be only of a few minutes. Also,
this was a retrospective analysis. Prior antibiotic use was
considered in the event that the patient received at least one
dose of antibiotics during the week before blood extraction. The
effect of this would probably differ depending on the number of
antibiotic doses received, the number of days on which antibiotics
were taken, and the time between the last antibiotic dose and
blood extraction. Nevertheless, it seems important to consider the
prior administration of antibiotics to try to optimize the extraction
of blood cultures.
In conclusion, the time at which growth is detected in blood
cultures using the automated BacT/Alert system could inform
clinicians of whether the culture represents true bacteraemia or
not, pending the time required for a deﬁnitive identiﬁcation of the
microorganism involved. The factors that inﬂuence these growth
times are the association of the culture with true bacteraemia, the
prior use of antibiotic therapy, and the type of microorganism.
These results should be conﬁrmed in other studies in different
geographic areas.Conﬂict of interest: The authors declare no conﬂicts of interest.
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